UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Use of Model-Based Tumor-Size Metrics to Predict Survival

Clinical pharmacology and therapeutics, 2014-08, Vol.96 (2), p.133-135

2014

Volltextzugriff (PDF)

Influence of Alpha-1 Glycoprotein Acid Concentrations and Variants on Atazanavir Pharmacokinetics in HIV-Infected Patients Included in the ANRS 107 Trial

Antimicrobial Agents and Chemotherapy, 2010-02, Vol.54 (2), p.614-619

2010

Volltextzugriff (PDF)

Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features

Clinical microbiology and infection, 2011-04, Vol.17 (4), p.557-565

2011

Volltextzugriff (PDF)

Effect of Adherence as Measured by MEMS, Ritonavir Boosting, and CYP3A5 Genotype on Atazanavir Pharmacokinetics in Treatment-Naive HIV-Infected Patients

Clinical pharmacology and therapeutics, 2012-11, Vol.92 (5), p.575-583

2012

Volltextzugriff (PDF)

The Emergence of Linezolid Resistance among Enterococci in Intestinal Microbiota of Treated Patients Is Unrelated to Individual Pharmacokinetic Characteristics

Antimicrobial agents and chemotherapy, 2014-05, Vol.58 (5), p.2681-2687

2014

Volltextzugriff (PDF)

Pharmacokinetic Similarity of Biologics: Analysis Using Nonlinear Mixed-Effects Modeling

Clinical pharmacology and therapeutics, 2012-02, Vol.91 (2), p.234-242

2012

Volltextzugriff (PDF)

Overview of model‐building strategies in population PK/PD analyses: 2002–2004 literature survey

British journal of clinical pharmacology, 2007-11, Vol.64 (5), p.603-612

2007

Volltextzugriff (PDF)

Joint Population Pharmacokinetic Analysis of Zidovudine, Lamivudine, and Their Active Intracellular Metabolites in HIV Patients

Antimicrobial Agents and Chemotherapy, 2011-07, Vol.55 (7), p.3423-3431

2011

Volltextzugriff (PDF)

The ISoP Standards and Best Practices Committee

Clinical pharmacology and therapeutics, 2014-06, Vol.95 (6), p.581-582

2014

Volltextzugriff (PDF)

Pharmacokinetic and Pharmacodynamic Variability of Fluindione in Octogenarians

Clinical pharmacology and therapeutics, 2012-05, Vol.91 (5), p.777-786

2012

Volltextzugriff (PDF)

Population kinetics and conditional assessment of the optimal dosage regimen using the P-PHARM software package

Anticancer research, 1994-11, Vol.14 (6A), p.2321

1994

Volltextzugriff (PDF)

Effect of oseltamivir, zanamivir or oseltamivir― zanamivir combination treatments on transmission of influenza in households

Antiviral therapy, 2012-01, Vol.17 (6), p.1085-1090

2012

Volltextzugriff (PDF)

Population pharmacokinetic analysis for nelfinavir and its metabolite M8 in virologically controlled HIV‐infected patients on HAART

British journal of clinical pharmacology, 2005-10, Vol.60 (4), p.390-403

2005

Volltextzugriff (PDF)

Comparison of lithium concentrations in red blood cells and plasma in samples collected for TDM, acute toxicity, or acute-on-chronic toxicity

European journal of clinical pharmacology, 2003-11, Vol.59 (8-9), p.583-587

2003

Volltextzugriff (PDF)

Nonparametric estimation of population characteristics of the kinetics of lithium from observational and experimental data : individualization of chronic dosing regimen using a new Bayesian approach

Therapeutic drug monitoring, 1994-06, Vol.16 (3), p.258-269

1994

Volltextzugriff (PDF)

Clinical pharmacokinetics of zidovudine : inter and intraindividual variability and relationship to long term efficacy and toxicity

European journal of clinical pharmacology, 1993-12, Vol.45 (5), p.397-407

1993

Volltextzugriff (PDF)

Population pharmacokinetics of clozapine evaluated with the nonparametric maximum likelihood method

British journal of clinical pharmacology, 1997-11, Vol.44 (5), p.447-453

1997

Volltextzugriff (PDF)

Population pharmacokinetic analysis and optimization of the experimental design for mizolastine solution in children

Journal of pharmacokinetics and pharmacodynamics, 2001-06, Vol.28 (3), p.299-319

2001

Volltextzugriff (PDF)

Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients

British journal of clinical pharmacology, 2008-04, Vol.65 (4), p.548-557

2008

Volltextzugriff (PDF)

Influence of pharmacogenetics on indinavir disposition and short-term response in HIV patients initiating HAART

European journal of clinical pharmacology, 2009-07, Vol.65 (7), p.667-678

2009

Volltextzugriff (PDF)

Bayesian design criteria : computation, comparison, and application to a pharmacokinetic and a pharmacodynamic model

Journal of pharmacokinetics and biopharmaceutics, 1995-02, Vol.23 (1), p.101-125

1995

Volltextzugriff (PDF)

Robust optimal design for the estimation of hyperparameters in population pharmacokinetics

Journal of pharmacokinetics and biopharmaceutics, 1998-12, Vol.26 (6), p.689-716

1998

Volltextzugriff (PDF)

Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients

Clinical pharmacology and therapeutics, 1998-01, Vol.63 (1), p.64-78

1998

Volltextzugriff (PDF)

Constructing a prediction interval for time to reach a threshold concentration based on a population pharmacokinetic analysis : An application to basiliximab in renal transplantation

Journal of pharmacokinetics and biopharmaceutics, 1999-04, Vol.27 (2), p.213-230

1999

Volltextzugriff (PDF)

New strategies in drug development and clinical evaluation : the population approach : commentary on an action for co-operative research

European journal of clinical pharmacology, 1993-09, Vol.45 (2), p.93-94

1993

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

KollektionTaylor & Francis:Master (3349 titles)

ThemaPhysical Sciences

ThemaPharmacology. Drug Treatments

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(54)

Sprache

Englisch
(54)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(54)
Medical Sciences
(54)
Life Sciences & Biomedicine
(50)
Science & Technology
(50)
Humans
(46)
Pharmacology & Pharmacy
(46)
Male
(27)
Adult
(26)
Female
(26)
Middle Aged
(22)
Pharmacokinetics
(17)
Aged
(16)
Models, Biological
(14)
Infectious Diseases
(13)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(12)
Bayes Theorem
(11)
Hiv Infections - Drug Therapy
(11)
Human Viral Diseases
(11)
Viral Diseases
(11)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

8 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Use of Model-Based Tumor-Size Metrics to Predict Survival

Influence of Alpha-1 Glycoprotein Acid Concentrations and Variants on Atazanavir Pharmacokinetics in HIV-Infected Patients Included in the ANRS 107 Trial

Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features

Effect of Adherence as Measured by MEMS, Ritonavir Boosting, and CYP3A5 Genotype on Atazanavir Pharmacokinetics in Treatment-Naive HIV-Infected Patients

The Emergence of Linezolid Resistance among Enterococci in Intestinal Microbiota of Treated Patients Is Unrelated to Individual Pharmacokinetic Characteristics

Pharmacokinetic Similarity of Biologics: Analysis Using Nonlinear Mixed-Effects Modeling

Overview of model‐building strategies in population PK/PD analyses: 2002–2004 literature survey

Joint Population Pharmacokinetic Analysis of Zidovudine, Lamivudine, and Their Active Intracellular Metabolites in HIV Patients

The ISoP Standards and Best Practices Committee

Pharmacokinetic and Pharmacodynamic Variability of Fluindione in Octogenarians

Population kinetics and conditional assessment of the optimal dosage regimen using the P-PHARM software package

Effect of oseltamivir, zanamivir or oseltamivir― zanamivir combination treatments on transmission of influenza in households

Population pharmacokinetic analysis for nelfinavir and its metabolite M8 in virologically controlled HIV‐infected patients on HAART

Comparison of lithium concentrations in red blood cells and plasma in samples collected for TDM, acute toxicity, or acute-on-chronic toxicity

Nonparametric estimation of population characteristics of the kinetics of lithium from observational and experimental data : individualization of chronic dosing regimen using a new Bayesian approach

Clinical pharmacokinetics of zidovudine : inter and intraindividual variability and relationship to long term efficacy and toxicity

Population pharmacokinetics of clozapine evaluated with the nonparametric maximum likelihood method

Population pharmacokinetic analysis and optimization of the experimental design for mizolastine solution in children

Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients

Influence of pharmacogenetics on indinavir disposition and short-term response in HIV patients initiating HAART

Bayesian design criteria : computation, comparison, and application to a pharmacokinetic and a pharmacodynamic model

Robust optimal design for the estimation of hyperparameters in population pharmacokinetics

Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients

Constructing a prediction interval for time to reach a threshold concentration based on a population pharmacokinetic analysis : An application to basiliximab in renal transplantation

New strategies in drug development and clinical evaluation : the population approach : commentary on an action for co-operative research

Aktive Filter

Suchergebnisse filtern